financetom
Business
financetom
/
Business
/
1stdibs.com Completes $25 Million Stock Buyback Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
1stdibs.com Completes $25 Million Stock Buyback Program
Jun 10, 2024 7:03 AM

09:37 AM EDT, 06/10/2024 (MT Newswires) -- 1stdibs.com ( DIBS ) said Monday that it has completed its stock buyback program, repurchasing 4.9 million shares for $25.2 million or an average price of $5.12 per share.

Included in the total is 3 million shares bought back from Insight Partners at an average per-share price of $5.23 in a privately negotiated transaction, the company said.

Price: 5.80, Change: +0.20, Percent Change: +3.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cal-Maine Foods Plans $40 Million Expansion of Cage-Free Production Facilities
Cal-Maine Foods Plans $40 Million Expansion of Cage-Free Production Facilities
Oct 7, 2024
04:48 PM EDT, 10/07/2024 (MT Newswires) -- Cal-Maine Foods ( CALM ) said Monday its board approved $40 million in new projects to expand its cage-free production facilities, including the addition of five new cage-free layer houses in Florida, Georgia, Utah and Texas. The company said it will fund the projects with cash on hand, sales of investment securities and...
Andrew Ng's fund makes first India investment with AI healthcare firm Jivi
Andrew Ng's fund makes first India investment with AI healthcare firm Jivi
Oct 7, 2024
Oct 8 (Reuters) - Computer scientist Andrew Ng-led AI Fund said on Tuesday it has invested in an Indian artificial intelligence healthcare firm named Jivi, the fund's first such investment in the country. India's booming AI segment is expected to grow more than double to up to $22 billion by 2027, according to a Nasscom-BCG report released earlier this year....
Procept BioRobotics Gets FDA Approval to Start Study for Prostate Cancer
Procept BioRobotics Gets FDA Approval to Start Study for Prostate Cancer
Oct 7, 2024
04:33 PM EDT, 10/07/2024 (MT Newswires) -- Procept BioRobotics ( PRCT ) said Monday that it has received approval from the US Food and Drug Administration for an investigational device exemption clinical trial to compare Aquablation therapy with radical prostatectomy. The study will enroll up to 280 patients at up to 50 centers and follow them for 10 years, the...
Elanco Animal Health Gets US FDA Approval for Credelio Quattro
Elanco Animal Health Gets US FDA Approval for Credelio Quattro
Oct 7, 2024
04:46 PM EDT, 10/07/2024 (MT Newswires) -- Elanco Animal Health ( ELAN ) said late Monday the US Food and Drug Administration has approved the company's Credelio Quattro canine oral parasiticide. This monthly chewable tablet for dogs eight weeks of age or older is expected to launch in Q1 of 2025, the company said. Shares of the company fell 1.9%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved